Robert F. Place

6.0k total citations · 2 hit papers
47 papers, 4.7k citations indexed

About

Robert F. Place is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert F. Place has authored 47 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 20 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert F. Place's work include MicroRNA in disease regulation (14 papers), RNA Interference and Gene Delivery (13 papers) and Epigenetics and DNA Methylation (8 papers). Robert F. Place is often cited by papers focused on MicroRNA in disease regulation (14 papers), RNA Interference and Gene Delivery (13 papers) and Epigenetics and DNA Methylation (8 papers). Robert F. Place collaborates with scholars based in United States, China and Japan. Robert F. Place's co-authors include Long‐Cheng Li, Emily J. Noonan, Deepa Pookot, Rajvir Dahiya, Charles Giardina, Vera Huang, Shinji Urakami, Steven T. Okino, Long-Cheng Li and Kellie K. Bowen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Robert F. Place

47 papers receiving 4.6k citations

Hit Papers

MicroRNA-373 induces expression of genes with complementa... 2006 2026 2012 2019 2008 2006 250 500 750

Peers

Robert F. Place
Wenbo Li China
Luiz O. F. Penalva United States
Benjamin C. Hitz United States
Gary Brewer United States
Robert F. Place
Citations per year, relative to Robert F. Place Robert F. Place (= 1×) peers Xiaojing Yang

Countries citing papers authored by Robert F. Place

Since Specialization
Citations

This map shows the geographic impact of Robert F. Place's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Place with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Place more than expected).

Fields of papers citing papers by Robert F. Place

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Place. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Place. The network helps show where Robert F. Place may publish in the future.

Co-authorship network of co-authors of Robert F. Place

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Place. A scholar is included among the top collaborators of Robert F. Place based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Place. Robert F. Place is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Moorim, Zubao Gan, Vera Huang, et al.. (2024). Intrathecal administration of a novel siRNA modality extends survival and improves motor function in the SOD1G93A ALS mouse model. Molecular Therapy — Nucleic Acids. 35(1). 102147–102147. 9 indexed citations
2.
Krieger, Christine C., Robert F. Place, Bernice Marcus‐Samuels, et al.. (2016). TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis. The Journal of Clinical Endocrinology & Metabolism. 101(6). 2340–2347. 114 indexed citations
3.
Neumann, Susanne, Mary Jane Cullen, Elena Eliseeva, et al.. (2016). An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties. Frontiers in Endocrinology. 7. 105–105. 15 indexed citations
4.
Krieger, Christine C., Susanne Neumann, Robert F. Place, Bernice Marcus‐Samuels, & Marvin C. Gershengorn. (2014). Bidirectional TSH and IGF-1 Receptor Cross Talk Mediates Stimulation of Hyaluronan Secretion by Graves' Disease Immunoglobins. The Journal of Clinical Endocrinology & Metabolism. 100(3). 1071–1077. 106 indexed citations
5.
Kang, Moo Rim, Glen Yang, Robert F. Place, et al.. (2012). Intravesical Delivery of Small Activating RNA Formulated into Lipid Nanoparticles Inhibits Orthotopic Bladder Tumor Growth. Cancer Research. 72(19). 5069–5079. 87 indexed citations
6.
Place, Robert F., Ji Wang, Emily J. Noonan, et al.. (2012). Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Molecular Therapy — Nucleic Acids. 1. e15–e15. 48 indexed citations
7.
Huang, Vera, Robert F. Place, Victoria Portnoy, et al.. (2011). Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Research. 40(4). 1695–1707. 236 indexed citations
8.
Portnoy, Victoria, Vera Huang, Robert F. Place, & Long‐Cheng Li. (2011). Small RNA and transcriptional upregulation. Wiley Interdisciplinary Reviews - RNA. 2(5). 748–760. 133 indexed citations
9.
Wang, Ji, Robert F. Place, Vera Huang, et al.. (2010). Prognostic Value and Function of KLF4 in Prostate Cancer: RNAa and Vector-Mediated Overexpression Identify KLF4 as an Inhibitor of Tumor Cell Growth and Migration. Cancer Research. 70(24). 10182–10191. 118 indexed citations
10.
Noonan, Emily J., Robert F. Place, Shashwati Basak, Deepa Pookot, & Long‐Cheng Li. (2010). miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget. 1(5). 349–358. 125 indexed citations
11.
Baumann, Gerd, Robert F. Place, & Zeno Földes‐Papp. (2010). Meaningful Interpretation of Subdiffusive Measurements in Living Cells (Crowded Environment) by Fluorescence Fluctuation Microscopy. Current Pharmaceutical Biotechnology. 11(5). 527–543. 18 indexed citations
12.
Place, Robert F., Emily J. Noonan, Zeno Földes‐Papp, & Long‐Cheng Li. (2010). Defining Features and Exploring Chemical Modifications to Manipulate RNAa Activity. Current Pharmaceutical Biotechnology. 11(5). 518–526. 67 indexed citations
13.
Whitson, Jared M., Emily J. Noonan, Deepa Pookot, Robert F. Place, & Rajvir Dahiya. (2009). Double stranded‐RNA‐mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma. International Journal of Cancer. 125(2). 446–452. 29 indexed citations
14.
Place, Robert F., Long‐Cheng Li, Deepa Pookot, Emily J. Noonan, & Rajvir Dahiya. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proceedings of the National Academy of Sciences. 105(5). 1608–1613. 978 indexed citations breakdown →
15.
Chen, Zhong, Robert F. Place, Zhejun Jia, et al.. (2008). Antitumor effect of dsRNA-induced p21WAF1/CIP1 gene activation in human bladder cancer cells. Molecular Cancer Therapeutics. 7(3). 698–703. 79 indexed citations
16.
Noonan, Emily J., Robert F. Place, Charles Giardina, & Lawrence E. Hightower. (2007). Hsp70B′ regulation and function. Cell Stress and Chaperones. 12(3). 219–219. 32 indexed citations
17.
Noonan, Emily J., Robert F. Place, Reza J. Rasoulpour, Charles Giardina, & Lawrence E. Hightower. (2006). Cell number‐dependent regulation of Hsp70B′ expression: Evidence of an extracellular regulator. Journal of Cellular Physiology. 210(1). 201–211. 30 indexed citations
18.
Place, Robert F., Emily J. Noonan, & Charles Giardina. (2005). HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes IκBα. Biochemical Pharmacology. 70(3). 394–406. 154 indexed citations
19.
Place, Robert F., et al.. (2003). Induced stabilization of IκBα can facilitate its re‐synthesis and prevent sequential degradation. Journal of Cellular Physiology. 195(3). 470–478. 13 indexed citations
20.
Inan, Mehmet Sait, et al.. (2000). I?B?-related proteins in normal and transformed colonic epithelial cells. Molecular Carcinogenesis. 29(1). 25–36. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026